Related Experiment Video
Updated: Aug 17, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Regulation of bone homeostasis by MERTK and TYRO3
Janik Engelmann1,2,3,4,5, Jennifer Zarrer6,7,8, Victoria Gensch1,2,3,4,5
1Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Targeting TAM receptors MERTK and TYRO3 in osteoblasts impacts bone mass. Blocking MERTK with R992 promotes bone formation and counters cancer-induced bone loss, offering potential osteoanabolic therapy.
Area of Science:
- Bone biology and homeostasis
- Cancer-induced bone loss
- TAM receptor signaling
Background:
- Bone homeostasis relies on osteoblasts and osteoclasts.
- TAM receptors MERTK and TYRO3 influence osteoblast function.
- Dysregulation contributes to bone diseases and cancer complications.
Purpose of the Study:
- Investigate the reciprocal roles of MERTK and TYRO3 in osteoblast biology.
- Elucidate the molecular mechanisms underlying their effects.
- Evaluate MERTK blockade as a therapeutic strategy for bone loss and cancer.
Main Methods:
- Osteoblast-specific gene deletion of MERTK and TYRO3 in mice.
- Pharmacologic MERTK inhibition using R992.
- Assessment of bone mass, osteoblast differentiation, and cancer models.
Main Results:
- MERTK deletion increased bone mass; TYRO3 deletion decreased it.
- MERTK signaling negatively regulates osteoblast differentiation via the VAV2-RHOA-ROCK axis.
- R992 treatment enhanced bone formation and reduced cancer-related bone loss and metastasis.
Conclusions:
- MERTK and TYRO3 are key regulators of bone homeostasis with opposing functions.
- MERTK blockade with R992 demonstrates osteoanabolic potential.
- MERTK inhibition is a promising therapeutic avenue for bone disorders and cancer treatment.
More Related Videos
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Skeleton and Calcium Homeostasis
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

